Addendum: Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series

PDF  |  How to cite

Oncotarget. 2023; 14:753-753. https://doi.org/10.18632/oncotarget.28480

Metrics: PDF 446 views  |   ?  

Mark Chang1, Wolfram Samlowski2,3,4, and Raul Meoz2,3

1University Medical Center of Southern Nevada, Las Vegas, NV 89102, USA
2Comprehensive Cancer Centers of Nevada, Las Vegas, NV 89148, USA
3Department of Internal Medicine, University of Nevada, Las Vegas (UNLV), Las Vegas, NV 89102, USA
4Department of Internal Medicine, University of Nevada, Reno, NV 89557, USA

Published: August 10, 2023

Copyright: © 2023 Chang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: No external funding was procured for this research.

Original article: Oncotarget. 2023; 14:709-718. DOI: https://doi.org/10.18632/oncotarget.28470.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28480